Abstract:Insufficient vascularization is considered to be one of the main factors limiting the clinical success of tissue-engineered constructs. In order to evaluate new strategies that aim at improving vascularization, reliable methods are required to make the in-growth of new blood vessels into bioartificial scaffolds visible and quantify the results. Over the past couple of years, our group has introduced a full skin defect model that enables the direct visualization of blood vessels by transillumination and provide… Show more
“…All animal procedures were performed strictly adhering to protocols approved by the Institutional Animal Care and Use Committee at UC Davis. Two excisional wounds were generated bilaterally on the flanks of immune deficient NOD/SCID IL2Rγ –/– (NSG) mice, as previously described (Egaña et al, 2009 ; Schenck et al, 2014 ). Briefly, animals were placed under anesthesia (1.5–3% isoflurane), fur was shaved and an area of skin was removed on both the left and/or right flank of the animal using a 10 mm biopsy punch.…”
Many therapies using mesenchymal stem cells (MSC) rely on their ability to produce and release paracrine signals with chemotactic and pro-angiogenic activity. These characteristics, however, are mostly studied under standard in vitro culture conditions. In contrast, various novel cell-based therapies imply pre-seeding MSC into bio-artificial scaffolds. Here we describe human bone marrow-derived MSC seeded in Integra matrices, a common type of scaffold for dermal regeneration (SDR). We show and measured the distribution of MSC within the SDR, where cells clearly establish physical interactions with the scaffold, exhibiting constant metabolic activity for at least 15 days. In the SDR, MSC secrete VEGF and SDF-1α and induce transwell migration of CD34+ hematopoietic/endothelial progenitor cells, which is inhibited in the presence of a CXCR4/SDF-1α antagonist. MSC in SDR respond to hypoxia by altering levels of angiogenic signals such as Angiogenin, Serpin-1, uPA, and IL-8. Finally, we show that MSC-containing SDR that have been pre-incubated in hypoxia show higher infiltration of endothelial cells after implantation into immune deficient mice. Our data show that MSC are fully functional ex vivo when implanted into SDR. In addition, our results strongly support the notion of hypoxic pre-conditioning MSC-containing SDR, in order to promote angiogenesis in the wounds.
“…All animal procedures were performed strictly adhering to protocols approved by the Institutional Animal Care and Use Committee at UC Davis. Two excisional wounds were generated bilaterally on the flanks of immune deficient NOD/SCID IL2Rγ –/– (NSG) mice, as previously described (Egaña et al, 2009 ; Schenck et al, 2014 ). Briefly, animals were placed under anesthesia (1.5–3% isoflurane), fur was shaved and an area of skin was removed on both the left and/or right flank of the animal using a 10 mm biopsy punch.…”
Many therapies using mesenchymal stem cells (MSC) rely on their ability to produce and release paracrine signals with chemotactic and pro-angiogenic activity. These characteristics, however, are mostly studied under standard in vitro culture conditions. In contrast, various novel cell-based therapies imply pre-seeding MSC into bio-artificial scaffolds. Here we describe human bone marrow-derived MSC seeded in Integra matrices, a common type of scaffold for dermal regeneration (SDR). We show and measured the distribution of MSC within the SDR, where cells clearly establish physical interactions with the scaffold, exhibiting constant metabolic activity for at least 15 days. In the SDR, MSC secrete VEGF and SDF-1α and induce transwell migration of CD34+ hematopoietic/endothelial progenitor cells, which is inhibited in the presence of a CXCR4/SDF-1α antagonist. MSC in SDR respond to hypoxia by altering levels of angiogenic signals such as Angiogenin, Serpin-1, uPA, and IL-8. Finally, we show that MSC-containing SDR that have been pre-incubated in hypoxia show higher infiltration of endothelial cells after implantation into immune deficient mice. Our data show that MSC are fully functional ex vivo when implanted into SDR. In addition, our results strongly support the notion of hypoxic pre-conditioning MSC-containing SDR, in order to promote angiogenesis in the wounds.
“…In order to quantify the rate of vascularization over the wound, tissue transillumination and digital segmentation was performed as described before [21]. Briefly, the skin from the back of the animals was removed and stretched out on a petri dish over a transilluminator device.…”
Section: Visualization and Quantification Of The Vascular Networkmentioning
The use of artificial tissues in regenerative medicine is limited due to hypoxia. As a strategy to overcome this drawback, we have shown that photosynthetic biomaterials can produce and provide oxygen independently of blood perfusion by generating chimeric animal-plant tissues during dermal regeneration. In this work, we demonstrate the safety and efficacy of photosynthetic biomaterials in vivo after engraftment in a fully immunocompetent mouse skin defect model. Further, we show that it is also possible to genetically engineer such photosynthetic scaffolds to deliver other key molecules in addition to oxygen. As a proof-of-concept, biomaterials were loaded with gene modified microalgae expressing the angiogenic recombinant protein VEGF. Survival of the algae, growth factor delivery and regenerative potential were evaluated in vitro and in vivo. This work proposes the use of photosynthetic gene therapy in regenerative medicine and provides scientific evidence for the use of engineered microalgae as an alternative to deliver recombinant molecules for gene therapy.
“…Experiments were performed on female nu/nu mice of 6-8 weeks age and body weight of 6 20-25 g (Charles River, Sulzfeld, Germany). Under inhalative anesthesia (Isoflurane, Baxter Germany, Unterschleissheim, Germany), a bilateral 10 mm full skin defect was created as we described before [19]. Control and HULK scaffolds were implanted and covered with a transparent dressing (V.A.C.® Drape, KCI Medical Products, Wimborne Dorset, UK).…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.